Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

Invivyd Inc (IVVD)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Invivyd's earnings

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
2.270 +0.080    +3.65%
16:00:29 - Closed. Currency in USD ( Disclaimer )
After Hours
2.200
-0.070
-3.084%
17:48:16 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 830,157
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 2.240 - 2.380
Invivyd 2.270 +0.080 +3.65%

Invivyd Inc Company Profile

 
Get an in-depth profile of Invivyd Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

95

Equity Type

ORD

Invivyd, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. It developed INVYMAB, a platform that combines viral surveillance and predictive modeling with advanced antibody engineering. The company's pipeline includes PEMGRADA (pemivibart) injection, a half-life extended investigational monoclonal antibody (mAb) for the prevention of COVID-19 in adults and adolescents; VYD2311, an mAb candidate which is in preclinical studies for the prevention or treatment for COVID-19; and adintrvimab, that is in phase 3 clinical trials for the prevention or treatment of COVID-19. It also has discovery stage candidates for the prevention of seasonal influenza and COVID-19. Invivyd, Inc. has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies; and the Scripps Research Institute to perform research activities to identify vaccine candidates for the prevention, diagnosis or treatment of influenza or beta coronaviruses. The company was formerly known as Adagio Therapeutics, Inc. and changed its name to Invivyd, Inc. in September 2022. Invivyd, Inc. was incorporated in 2020 and is headquartered in Waltham, Massachusetts.

Contact Information

Address 1601 Trapelo Road Suite 178
Waltham, 02451
United States
Phone 781 819 0080
Fax -
Web invivyd.com

Top Executives

Name Age Since Title
Marc William Elia 47 2022 Independent Chairperson of the Board
Clive A. Meanwell 66 2022 Director
Terrance G. McGuire 68 2020 Director
Tomas J. Heyman 67 2021 Independent Director
Tamsin Berry 42 2022 Director
Michael Stephen Wyzga 69 2021 Independent Director
Christine Regan Lindenboom 43 2022 Independent Director
Sara Cotter 43 2023 Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

IVVD Comments

Write your thoughts about Invivyd Inc
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Luka Tsirekidze
Luka Tsirekidze Apr 19, 2023 2:02PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
this stock have big potential now
Reply
2 0
Report
Gudis Gudis
Gudis Gudis Mar 31, 2022 4:07AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Pump should easy today, probably closes around 4.00
Reply
2 0
Report
Sharron Jalimsing
Sharron Jalimsing Feb 04, 2022 8:36AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I think it has good potential to go much higher. At the moment it’s 7.85. In three weeks time (from it’s lowest point until now) it went approximately 50% upside. I think, for the long term, it will go back to 50 or higher.
Reply
0 2
Report
Sharron Jalimsing
Sharron Jalimsing Feb 04, 2022 8:36AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I have sold them (with loss). Now that the covidmeasures in the world have been reduced. It seems like a high risk at the moment. Maybe I will buy them again when they are around 4$
Reply
0 0
Report
Keith Whitaker
Keith Whitaker Feb 04, 2022 8:36AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Sharron Jalimsing you called that one lol
Reply
0 0
Report
Keith Whitaker
Keith Whitaker Feb 04, 2022 8:36AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Sharron Jalimsing you called that one lol
Reply
0 0
Report
Donald bessette jr
Donald bessette jr Jan 25, 2022 8:11PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I'm starting to think Its not gunna come back up
Reply
0 0
Report
Shawn Floyd
Shawn Floyd Jan 09, 2022 7:05PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
this is simply a stock that will skyrocket on good news and crash on bad news. it is a high demand industry if they create a vaccine that works better then the rest it will be a great investment at these prices
Reply
1 0
Report
Donald bessette jr
Donald bessette jr Jan 06, 2022 7:21PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
think it will go back up or ??????
Reply
2 0
Report
Future com
Future com Dec 27, 2021 11:41AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Should get 10 soon from news
Reply
0 0
Report
Abu Abdullah
Abu Abdullah Dec 18, 2021 1:59PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
When it will go back to above 20?
Reply
1 2
Report
Vítor Teixeira
Vítor Teixeira Dec 18, 2021 1:59PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
😬😬😬
Reply
0 0
Report
Jake Milkanin
Jake Milkanin Dec 18, 2021 1:59PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
when I recieve 50 virginians
Reply
0 0
Report
Yusuf Atanda
Yusuf Atanda Dec 16, 2021 3:59PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
what a day!!!
Reply
1 0
Report
Ab High
Ab High Dec 16, 2021 1:34PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
15
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email